Loading clinical trials...
Loading clinical trials...
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term (APPOINT): A Pilot Randomized Controlled Trial
Conditions
Interventions
Cefazolin
Placebo
+1 more
Locations
1
United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Start Date
December 12, 2018
Primary Completion Date
June 1, 2021
Completion Date
June 1, 2021
Last Updated
April 19, 2024
NCT07037459
NCT07351045
NCT07244458
NCT07508241
NCT07395687
NCT05746039
Lead Sponsor
University of Oklahoma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions